<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01986504</url>
  </required_header>
  <id_info>
    <org_study_id>NA_00044645</org_study_id>
    <nct_id>NCT01986504</nct_id>
  </id_info>
  <brief_title>The Johns Hopkins Transplant Infectious Diseases Prospective Cohort Study</brief_title>
  <official_title>The Johns Hopkins Transplant Infectious Diseases Prospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Transplant Infectious Diseases Prospective Cohort Study facilitates the prospective&#xD;
      identification and collection of data of infectious disease complications in order to&#xD;
      determine the epidemiology, risk factors, and outcomes of patients who receive solid organ or&#xD;
      stem cell or plastic surgery transplants at Johns Hopkins and other transplant centers. It is&#xD;
      essential for the care and treatment of this population to employ a mechanism for&#xD;
      investigators to centralize these datasets, using standardized definitions of infectious&#xD;
      complications. This protocol outlines the procedures to be utilized in order to prospectively&#xD;
      follow the diagnosis and treatment of infectious complications in transplant patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients are approached at their transplant screening visit, if possible, or during their&#xD;
      hospital stay (before or after transplant) in order to introduce the study and obtain&#xD;
      informed consent for participation. A letter to transplant physicians will introduce this&#xD;
      study. Data collection will begin immediately upon consent and continue for up to five years.&#xD;
      The informed consent form specifically requests permission to contact the subject in the&#xD;
      future to verify information or if the subject is lost to follow up by Transplant services.&#xD;
&#xD;
      The Day of transplant will be considered day 0 for enrollment in this observational study.&#xD;
      Data will be collected on clinical template forms completed by study team members, as&#xD;
      infectious complications become apparent in either outpatient ID clinics or on the inpatient&#xD;
      service. A member of the research team will complete data collection in the registry,&#xD;
      maintained on the REDCap platform. In addition, patient electronic records will be reviewed&#xD;
      every 3 months to identify and record infectious complications, treatments administered, and&#xD;
      outcomes. During these intervals, subjects will be contacted by phone to review the same&#xD;
      outcomes.&#xD;
&#xD;
      Creation of the registry relies on use of standardized definitions to define infections. An&#xD;
      electronic database has been constructed in the REDCap system, documenting subject&#xD;
      demographics, transplant variables, infection variables, treatments administered, and overall&#xD;
      outcomes, during each interim time period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2011</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Epidemiology and Outcomes</measure>
    <time_frame>6 years</time_frame>
    <description>This protocol will enable the creation of a prospective registry of infectious complications in transplant patients, to be used for research epidemiology and outcomes, and, ultimately, to improve patient care.</description>
  </primary_outcome>
  <enrollment type="Actual">1058</enrollment>
  <condition>Transplantation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Hematopoietic stem cell (bone marrow) and solid organ transplant patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Hematopoietic stem cell (bone marrow) and solid organ transplant patients -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <study_first_submitted>November 11, 2013</study_first_submitted>
  <study_first_submitted_qc>November 11, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2013</study_first_posted>
  <last_update_submitted>July 18, 2016</last_update_submitted>
  <last_update_submitted_qc>July 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johns Hopkins University</investigator_affiliation>
    <investigator_full_name>Kieren Marr</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Infection</keyword>
  <keyword>Cohort</keyword>
  <keyword>Prospective</keyword>
  <keyword>Epidemiology</keyword>
  <keyword>Outcome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

